* Sun Pharmaceutical Industries Ltd rises 1.1 percentto near a record high and a second day of gains, after acompetitor raised revenue guidance citing strong sale of ageneric antibiotic also sold by Sun Pharma.* Hikma Pharmaceuticals Plc on Monday raised itsfull-year revenue forecast for the second time in as many monthson strong sales of its generic version of antibioticdoxycycline. * "We expect this product to easily contribute around US$60-80million in sales in FY14 for Sun," Macquarie said in a report onWednesday referring to generic doxycycline. (abhishek.vishnoi@thomsonreuters.com /;abhishek.vishnoi.thomsonreuters.com@reuters.net)
TOP NEWS: Hikma Pharmaceuticals upgrades Generics and Branded guidance
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday updated its full year guidance across its divisions after reporting continued "strong momentum" in a trading update.
Read more